⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514513 | 0.70 | — | — | |
| SCHEMBL18335106 | 0.70 | — | — | |
| SCHEMBL15509358 | 0.70 | — | — | |
| SCHEMBL9161235 | 0.70 | — | — | |
| SCHEMBL443045 | 0.59 | — | — | |
| SCHEMBL207875 | 0.59 | — | — | |
| SCHEMBL4184176 | 0.59 | — | — | |
| SCHEMBL829504 | 0.56 | — | — | |
| SCHEMBL569978 | 0.56 | — | — | |
| SCHEMBL465091 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008610-A1 | MACROCYCLIC INHIBITORS OF KRAS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2024-01-11 | — | — | WO | claimed |
| US-20230278958-A1 | TRICYCLIC HETEROCYCLES | MERCK PATENT GMBH (DE) | 2023-09-07 | — | — | US | claimed |
| US-20230174538-A1 | Tricyclic heterocycles | MERCK PATENT GMBH (DE) | 2023-06-08 | — | — | US | claimed |
| EP-4185564-A1 | TRICYCLIC HETEROCYCLES | Merck Patent GmbH (DE) | 2023-05-31 | — | — | EP | claimed |
| WO-2023078813-A1 | HETEROBIFUNCTIONAL MOLECULES AS TEAD INHIBITORS | MERCK PATENT GMBH (DE) | 2023-05-11 | — | — | WO | claimed |
| EP-4146652-A1 | TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS | Merck Patent GmbH (DE) | 2023-03-15 | — | — | EP | claimed |
| WO-2021224291-A1 | TRICYCLIC HETEROCYCLES USEFUL AS TEAD BINDERS | MERCK PATENT GMBH (DE) | 2021-11-11 | — | — | WO | claimed |
| CN-106687458-B | Substituted oxopyridine derivatives | 拜耳制药股份公司 | 2020-10-27 | — | — | CN | claimed |
| US-20200317629-A1 | BENZO-FUSED HETEROCYCLIC DERIVATIVES USEFUL AS AGONISTS OF GPR120 | JANSSEN PHARMACEUTICA NV (BE) | 2020-10-08 | — | — | US | claimed |
| US-10414731-B2 | Substituted oxopyridine derivatives | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-09-17 | — | — | US | claimed |
| US-20020065257-A1 | 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties | RESEARCH TRIANGLE INSTITUTE (US) | 2002-05-30 | — | — | US | claimed |
| EP-1082337-A1 | 17 BETA-AMINO AND HYDROXYLAMINO-11 BETA-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 2001-03-14 | — | — | EP | claimed |
| EP-1082338-A1 | 17 BETA-NITRO-11 BETA-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 2001-03-14 | — | — | EP | claimed |
| EP-1060186-A1 | 20-KETO-11BETA-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 2000-12-20 | — | — | EP | claimed |
| US-6093707-A | A HORMONE INHIBITOR EXHIBITING POTENT ANTIPROGESTATIONAL ACTIVITY | RESEARCH TRIANGLE INSTITUTE (US) | 2000-07-25 | — | — | US | claimed |
| US-6020328-A | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties | RESEARCH TRIANGLE INSTITUTE (US) | 2000-02-01 | — | — | US | claimed |
| WO-1999062928-A1 | 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 1999-12-09 | — | — | WO | claimed |
| WO-1999062929-A1 | 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 1999-12-09 | — | — | WO | claimed |
| US-5962444-A | HORMONE INHIBITOR; HORMONE REPLACEMENT THERAPY | RESEARCH TRIANGLE INSTITUTE (US) | 1999-10-05 | — | — | US | claimed |
| WO-1999045022-A1 | 20-KETO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES | RESEARCH TRIANGLE INSTITUTE (US) | 1999-09-10 | — | — | WO | claimed |